These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 18604986)

  • 1. Integrin αvβ3 and LHRH Receptor Double Directed Nano-Analogue Effective Against Ovarian Cancer in Mice Model.
    Qi N; Zhou X; Ma N; Zhang J; Wang Z; Zhang X; Li A
    Int J Nanomedicine; 2024; 19():3071-3086. PubMed ID: 38562611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice.
    Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J
    Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer.
    Ye H; Liu X; Sun J; Zhu S; Zhu Y; Chang S
    BMC Cancer; 2016 Oct; 16(1):831. PubMed ID: 27793127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
    Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
    Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-tumor performance of docetaxel liposomes surface-modified with glycyrrhetinic acid.
    Li J; Xu H; Ke X; Tian J
    J Drug Target; 2012 Jun; 20(5):467-73. PubMed ID: 22577855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeting drug delivery of new-generation taxoids.
    Ojima I; Zuniga ES; Berger WT; Seitz JD
    Future Med Chem; 2012 Jan; 4(1):33-50. PubMed ID: 22168163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Administration of taxane-containing drugs].
    Barth J
    Pharm Unserer Zeit; 2005; 34(2):152-8. PubMed ID: 15803800
    [No Abstract]   [Full Text] [Related]  

  • 9. LHRHa aided liposomes targeting to human ovarian tumor cells: preparation and cellular uptake.
    Yuan WM; Song QG; Zhang ZR; Fu Y; Liu J; He Q
    Pharmazie; 2008 Jun; 63(6):434-8. PubMed ID: 18604986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ Development of new taxane formulations].
    Haas H
    Pharm Unserer Zeit; 2005; 34(2):115-21. PubMed ID: 15803795
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.